Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for IMTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 449.72M
March 31, 2026 522.60M
December 31, 2025 551.21M
September 30, 2025 506.23M
June 30, 2025 561.32M
March 31, 2025 587.37M
December 31, 2024 625.91M
September 30, 2024 547.44M
June 30, 2024 569.21M
March 31, 2024 609.07M
December 31, 2023 470.46M
September 30, 2023 387.52M
June 30, 2023 379.26M
March 31, 2023 358.33M
Date Value
December 31, 2022
September 30, 2022
June 30, 2022 339.12M
March 31, 2022 281.22M
December 31, 2021 165.03M
September 30, 2021 200.75M
June 30, 2021 228.65M
March 31, 2021 254.63M
December 31, 2020 283.84M
September 30, 2020 304.07M
June 30, 2020 96.65M
March 31, 2020 115.28M
December 31, 2019 134.00M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
MediGene AG --
InflaRx NV 181.23M
BioNTech SE 16.89B
Moderna, Inc. 5.138B
Intellia Therapeutics, Inc. 437.76M